Open original FDA record ↗Recall record
- FDA identifier
- Z-0822-2010
- Company in FDA record
- Diagnostic Hybrids Inc
- FDA classification date
- Feb 24, 2010
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
During QC post release monitoring, the firm determined that the monolayer culture of rabbit kidney cells previously distributed by the firm, appeared to contain another type of cells (monkey kidney cells).
Source facts
- Action
- Diagnostic Hybrids issued a "Product Notification" letter dated January 23, 2009 in addition to verbal communication of the affected product beginning January 21, 2009. The firm requested that all affected product be discarded /destroyed and not use for diagnostic testing. Consignees were asked to complete and return a Fax-Back form. For further information, contact Diagnostic Hybrids Technical Services at 1-866-344-3477 or 1-740-589-3300.
- Initiated
- 2009-01-21
- Root cause
- Process control
- Terminated
- 2010-09-21
- Distribution
- Worldwide Distribution -- United States (CA, FL, GA, MA, MO, NY, NJ, TN, TX and VA), Ontario Canada and Manitoba Canada.
- Recall number
- Z-0822-2010
- Recall status
- Terminated
- CDRH record ID
- 86385
- FDA classified
- 2010-02-24
- Recall event number
- 53702